Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ed T Buurman

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 4, 2015
Pharmacokinetics of the natural antibiotic negamycinJian Guo, Eric W Miele, April Chen, et al.
Bioorganic & Medicinal Chemistry Letters|October 27, 2012
Inhibitors of the acetyltransferase domain of N-acetylglucosamine-1-phosphate-uridylyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU). Part 2: Optimization of physical properties leading to antibacterial aryl sulfonamidesSuzanne S Stokes, Robert Albert, Ed T Buurman, et al.
The Journal of Biological Chemistry|October 11, 2011
In vitro validation of acetyltransferase activity of GlmU as an antibacterial target in Haemophilus influenzaeEd T Buurman, Beth Andrews, Ning Gao, et al.
Journal of Medicinal Chemistry|March 24, 2015
X-ray crystal structures of Escherichia coli RNA polymerase with switch region binding inhibitors enable rational design of squaramides with an improved fraction unbound to human plasma proteinVadim Molodtsov, Paul R Fleming, Charles J Eyermann, et al.
Journal of Bacteriology|July 31, 2012
Novel rapidly diversifiable antimicrobial RNA polymerase switch region inhibitors with confirmed mode of action in Haemophilus influenzaeEd T Buurman, Melinda A Foulk, Ning Gao, et al.
ACS Infectious Diseases|September 14, 2016
Illicit Transport via Dipeptide Transporter Dpp is Irrelevant to the Efficacy of Negamycin in Mouse Thigh Models of Escherichia coli InfectionDavid C McKinney, Natascha Bezdenejnih-Snyder, Krista Farrington, et al.
The Journal of Biological Chemistry|April 22, 2005
Candida albicans Pmr1p, a secretory pathway P-type Ca2+/Mn2+-ATPase, is required for glycosylation and virulenceSteven Bates, Donna M MacCallum, Gwyneth Bertram, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 7, 2016
Resistance mutations generate divergent antibiotic susceptibility profiles against translation inhibitorsAlexis I Cocozaki, Roger B Altman, Jian Huang, et al.
ACS Medicinal Chemistry Letters|August 20, 2015
Structural Insights Lead to a Negamycin Analogue with Improved Antimicrobial Activity against Gram-Negative PathogensDavid C McKinney, Gregory S Basarab, Alexis I Cocozaki, et al.
PHAGE (New Rochelle, N.Y.)|March 21, 2025
Addressing the Research and Development Gaps in Modern Phage TherapyPaul E Turner, Joana Azeredo, Ed T Buurman, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 4, 2015
Pharmacokinetics of the natural antibiotic negamycinJian Guo, Eric W Miele, April Chen, et al.
Bioorganic & Medicinal Chemistry Letters|October 27, 2012
Inhibitors of the acetyltransferase domain of N-acetylglucosamine-1-phosphate-uridylyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU). Part 2: Optimization of physical properties leading to antibacterial aryl sulfonamidesSuzanne S Stokes, Robert Albert, Ed T Buurman, et al.
The Journal of Biological Chemistry|October 11, 2011
In vitro validation of acetyltransferase activity of GlmU as an antibacterial target in Haemophilus influenzaeEd T Buurman, Beth Andrews, Ning Gao, et al.
Journal of Medicinal Chemistry|March 24, 2015
X-ray crystal structures of Escherichia coli RNA polymerase with switch region binding inhibitors enable rational design of squaramides with an improved fraction unbound to human plasma proteinVadim Molodtsov, Paul R Fleming, Charles J Eyermann, et al.
Journal of Bacteriology|July 31, 2012
Novel rapidly diversifiable antimicrobial RNA polymerase switch region inhibitors with confirmed mode of action in Haemophilus influenzaeEd T Buurman, Melinda A Foulk, Ning Gao, et al.
ACS Infectious Diseases|September 14, 2016
Illicit Transport via Dipeptide Transporter Dpp is Irrelevant to the Efficacy of Negamycin in Mouse Thigh Models of Escherichia coli InfectionDavid C McKinney, Natascha Bezdenejnih-Snyder, Krista Farrington, et al.
The Journal of Biological Chemistry|April 22, 2005
Candida albicans Pmr1p, a secretory pathway P-type Ca2+/Mn2+-ATPase, is required for glycosylation and virulenceSteven Bates, Donna M MacCallum, Gwyneth Bertram, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 7, 2016
Resistance mutations generate divergent antibiotic susceptibility profiles against translation inhibitorsAlexis I Cocozaki, Roger B Altman, Jian Huang, et al.
ACS Medicinal Chemistry Letters|August 20, 2015
Structural Insights Lead to a Negamycin Analogue with Improved Antimicrobial Activity against Gram-Negative PathogensDavid C McKinney, Gregory S Basarab, Alexis I Cocozaki, et al.
PHAGE (New Rochelle, N.Y.)|March 21, 2025
Addressing the Research and Development Gaps in Modern Phage TherapyPaul E Turner, Joana Azeredo, Ed T Buurman, et al.
Pageof 4